<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 3 Issue 4</issue_number>
<issue_period>2012(October - December)</issue_period>
<title>A COMPARATIVE STUDY OF NEUROPROTECTIVE POTENTIAL OF INHIBITOR OF PROLYL 4-HYDROXYLASE (PHD) IN RAT MODEL OF FOCAL CEREBRAL ISCHEMIA </title>
<abstract>Cerebral stroke can decrease the blood supply to the brain at this condition stimulate the hypoxia inducible factor provide the neuroprotection in cerebral stroke. Hypoxia-inducible factor1 (HIF-1) is hetrodimer composed of HIF-1a and HIF-1b protein subunits. This transcription factor is essential for the activation of hypoxia inducible gene like erythropoietin, some glucose transporters, the glycolytic enzymes, and vascular endothelial growth factor. Because HIF-1 activation may promote cell survival in hypoxic tissues, we studied the effect of hypoxic preconditioning on HIF-1 expression in rat brain. To support the role of HIF-1 in protective preconditioning we also studied the effect of on other known HIF-1 inducer, cobalt chloride on HIF-1 expression and neuroprotection in rat brain. HIF-1a and HIF-1b protein levels were markedly increased after seven days chronic treatment of COCl lessThan sub greaterThan 2 lessThan /sub greaterThan  different dose (15mg/kg, 17.5mg/kg, 20mg/kg, 22.5mg/kg) and moderately increased the brain protection, respectively compared with that of vehicle injected littermate controls.</abstract>
<authors>AADITYA SINGH AND SHIV BHADRA SINGH</authors>
<keywords>Hypoxia inducible factor, Prolyl hydroxylase inhibitor, Cerebral Stroke.</keywords>
<pages>322-330</pages>
</article>
</Journal>
